Clinical Trial Update: Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus [Phase 4]

View source ↗

Summary

Phase 4 trial comparing cyclosporine microemulsion versus tacrolimus in liver transplant recipients with Hepatitis C, assessing liver fibrosis; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Fibrosis

Drugs mentioned

• Cyclosporine microemulsion (Neoral) (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Liver Transplant, Hepatitis C | Phase 4 | Status: TERMINATED | Results posted: 2011-10-26